Highlights Cytokinetics, Incorporated Deutsche Boerse AG

Equities

KK3A

US23282W6057

Market Closed - Deutsche Boerse AG Other stock markets 08:11:14 31/05/2024 BST			5-day change	1st Jan Change
45 ^EUR	-0.44%		+1.35%	-39.19%

05-29	Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating	MT
05-28	Cytokinetics Closes $500 Million Stock Offering	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Cytokinetics Closes $500 Million Stock Offering	05-28	MT
Sector Update: Health Care Stocks Flat to Lower Premarket Thursday	05-23	MT
Nvidia Earnings Fuel Investor Optimism, Driving Premarket Gains for US Equity Futures	05-23	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Tech Stocks Rally on NVIDIA Earnings	05-23	MT
Stocks in motion: e.l.f Beauty soars along with Nvidia	05-23
Top Premarket Decliners	05-23	MT
Cytokinetics, Royalty Pharma Unveil up to $575 Million Funding to Advance Research Pipeline	05-22	MT
Cytokinetics Plans $500 Million Common Stock Offering -- Shares Drop After Hours	05-22	MT
Cytokinetics Q1 Net Loss Narrows, Revenue Declines	05-08	MT
Earnings Flash (CYTK) CYTOKINETICS INCORPORATED Posts Q1 Revenue $835,000, vs. Street Est of $0.9M	05-08	MT
Cytokinetics, Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
Cytokinetics, Incorporated Announces Topline Data from Phase 1 Clinical Study of Ck-4021586	05-08	CI
Cytokinetics, Incorporated Announces CEDAR-HCM Is Open to Enrollment	05-08	CI
Sector Update: Health Care Stocks Rise Friday Afternoon	04-05	MT
Cytokinetics Reports Positive Follow-On Data for Prospective Heart Medication; Shares Rise	04-05	MT
Cytokinetics Presents Additional 48-Week Data from Forest-Hcm, the Open Label Extension Clinical Study of Aficamten, At the American College of Cardiology 73rd Annual Scientific Session	04-05	CI
Cytokinetics Q4 Net Loss Narrows, Revenue Decreases; 2024 Outlook Issued	02-27	MT
Earnings Flash (CYTK) CYTOKINETICS INCORPORATED Reports Q4 Revenue $1.7M, vs. Street Est of $13.3M	02-27	MT
Cytokinetics, Incorporated Provides Revenue Guidance for 2024	02-27	CI
Cytokinetics, Incorporated Reports Earnings Results for the Full Year Ended December 31, 2023	02-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cytokinetics, Incorporated Deutsche Boerse AG

Equities

KK3A

US23282W6057

Highlights

Filters